• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.16% Nasdaq Down 0.08%

    Keryx Biopharmaceuticals Inc. (KERX)

    -NasdaqCM
    9.67 Down 0.17(1.73%) Jul 2, 4:00PM EDT
    Add to Portfolio
    Prev Close:9.84
    Open:9.91
    Bid:7.00 x 200
    Ask:10.40 x 100
    1y Target Est:21.60
    Beta:6.65
    Earnings Date:Aug 5 - Aug 10 (Est.)
    Day's Range:9.59 - 10.05
    52wk Range:8.84 - 18.48
    Volume:1,313,691
    Avg Vol (3m):1,693,020
    Market Cap:1.00B
    P/E (ttm):N/A
    EPS (ttm):-1.34
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for KERX

    Comparison

    Symbol% ChgMkt Cap
    KERXDown 1.73%1.00B
    BAXDown 1.44%20.82B
    SHPGUp 1.04%48.32B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):509.69
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-0.90
    Quarterly EPS Est (Jun-15) :-0.26
    Mean Recommendation*:1.8
    PEG Ratio (5 yr expected):-0.09

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Keryx Biopharmaceuticals, Inc., a biopharmaceutical company, focuses on providing therapies for patients with renal disease in the United States. Its lead product Auryxia (ferric citrate), an oral, ferric iron-based compound that has the capacity ... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback